Coagulopathy of Patients with COVID-19 is Associated with Infectious and Inflammatory Markers

References

• Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733. doi:10.1056/NEJMoa200101731978945
   PubMed Web of Science ®Google Scholar
• Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382(13):1199–1207. doi:10.1056/NEJMoa200131631995857
   PubMed Web of Science ®Google Scholar
• Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475–481. doi:10.1016/S2213-2600(20)30079-532105632
   PubMed Web of Science ®Google Scholar
• Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thrombosis Haemostasis. 2020.
   Web of Science ®Google Scholar
• Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thrombosis Haemostasis. 2020;18:844–847. doi:10.1111/jth.14768
   PubMed Web of Science ®Google Scholar
• Herold T, Jurinovic V, Arnreich C, et al. Level of IL-6 predicts respiratory failure in hospitalized symptomatic COVID-19 patients. medRxiv. 2020;2020.04.01.20047381.
   Google Scholar
• Qin C, Zhou L, Hu Z, et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis. 2020.
   Web of Science ®Google Scholar
• Liu J, Li S, Liu J, et al. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. medRxiv. 2020.
   Google Scholar
• Levi M, van der Poll T. Coagulation and sepsis. Thromb Res. 2017;149:38–44. doi:10.1016/j.thromres.2016.11.00727886531
   PubMed Web of Science ®Google Scholar
• Patel P, Walborn A, Rondina M, Fareed J, Hoppensteadt D. Markers of inflammation and infection in sepsis and disseminated intravascular coagulation. Clin Appl Thrombosis Hemostasis. 2019;25:1076029619843338. doi:10.1177/1076029619843338
   Web of Science ®Google Scholar
• Lippi G. Sepsis biomarkers: past, present and future. Clin Chem Lab Med. 2019;57:1281–1283. doi:10.1515/cclm-2018-134730710482
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–1062. doi:10.1016/S0140-6736(20)30566-332171076
   PubMed Web of Science ®Google Scholar
• Iba T, Levy JH, Warkentin TE, et al. Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation. J Thrombosis Haemostasis. 2019;17(11):1989–1994. doi:10.1111/jth.14578
   PubMed Web of Science ®Google Scholar
• Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related organ failure assessment) score to describe organ dysfunction/failure. Sepsis-Rel Prob Eur Soc Intensive Care Med Intensive Care Med . 1996;22:707–710.
   PubMed Web of Science ®Google Scholar
• Walborn A, Rondina M, Fareed J, Hoppensteadt D. Development of an algorithm to predict mortality in patients with sepsis and coagulopathy. Clin Appl Thrombosis Hemostasis. 2020;26:1076029620902849. doi:10.1177/1076029620902849
   Web of Science ®Google Scholar
• The Seventh Revised Trial Version of the Novel Coronavirus Pneumonia Diagnosis and Treatment Guidance. 2020 Available from: http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989.shtml.
   Google Scholar
• Rodelo JR, De la Rosa G, Valencia ML, et al. D-dimer is a significant prognostic factor in patients with suspected infection and sepsis. Am J Emerg Med. 2012;30:1991–1999. doi:10.1016/j.ajem.2012.04.03322795996
   PubMed Web of Science ®Google Scholar
• Li X, Wang L, Yan S, et al. Clinical characteristics of 25 death cases with COVID-19: a retrospective review of medical records in a single medical center, Wuhan, China. Int J Infect Dis. 2020;94:128–132. doi:10.1016/j.ijid.2020.03.05332251805
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-531986264
   PubMed Web of Science ®Google Scholar
• Iba T, Arakawa M, Di Nisio M, et al. Newly proposed sepsis-induced coagulopathy precedes international society on thrombosis and haemostasis overt-disseminated intravascular coagulation and predicts high mortality. J Intensive Care Med. 2018;885066618773679.
   Web of Science ®Google Scholar
• Hack CE. Fibrinolysis in disseminated intravascular coagulation. Semin Thromb Hemost. 2001;27(06):633–638. doi:10.1055/s-2001-1886711740686
   PubMed Web of Science ®Google Scholar
• Wong RS, Wu A, To KF, et al. Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis. BMJ. 2003;326(7403):1358–1362. doi:10.1136/bmj.326.7403.135812816821
   PubMed Web of Science ®Google Scholar
• Lillicrap D. Disseminated intravascular coagulation in patients with 2019-nCoV pneumonia. J Thrombosis Haemostasis. 2020;18(4):786–787. doi:10.1111/jth.14781
   PubMed Web of Science ®Google Scholar
• Chong PY, Chui P, Ling AE, et al. Analysis of deaths during the severe acute respiratory syndrome (SARS) epidemic in Singapore: challenges in determining a SARS diagnosis. Arch Pathol Lab Med. 2004;128:195–204.14736283
   PubMed Web of Science ®Google Scholar
• Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis. 2013;13(9):752–761. doi:10.1016/S1473-3099(13)70204-423891402
   PubMed Web of Science ®Google Scholar
• Saad M, Omrani AS, Baig K, et al. Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia. Int J Infect Dis. 2014;29:301–306. doi:10.1016/j.ijid.2014.09.00325303830
   PubMed Web of Science ®Google Scholar
• Stouthard JM, Levi M, Hack CE, et al. Interleukin-6 stimulates coagulation, not fibrinolysis, in humans. Thromb Haemost. 1996;76:738–742. doi:10.1055/s-0038-16506538950783
   PubMed Web of Science ®Google Scholar
• Undar L, Ertugrul C, Altunbas H, Akca S. Circadian variations in natural coagulation inhibitors protein C, protein S and antithrombin in healthy men: a possible association with interleukin-6. Thromb Haemost. 1999;81:571–575. doi:10.1055/s-0037-161452610235441
   PubMed Web of Science ®Google Scholar
• Song J, Park DW, Moon S, et al. Diagnostic and prognostic value of interleukin-6, pentraxin 3, and procalcitonin levels among sepsis and septic shock patients: a prospective controlled study according to the Sepsis-3 definitions. BMC Infect Dis. 2019;19:968. doi:10.1186/s12879-019-4618-731718563
   PubMed Web of Science ®Google Scholar
• Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395:565–574. doi:10.1016/S0140-6736(20)30251-832007145
   PubMed Web of Science ®Google Scholar
• Zhou Y, Fu B, Zheng X, et al. Aberrant pathogenic GM-CSF+ T cells and inflammatory CD14+CD16+ monocytes in severe pulmonary syndrome patients of a new coronavirus. bioRxiv. 2020;2020.02.12.945576.
   Google Scholar
• Wong CK, Lam CW, Wu AK, et al. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol. 2004;136:95–103. doi:10.1111/j.1365-2249.2004.02415.x15030519
   PubMed Web of Science ®Google Scholar
• Min CK, Cheon S, Ha NY, et al. Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity. Sci Rep. 2016;6:25359. doi:10.1038/srep2535927146253
   PubMed Web of Science ®Google Scholar
• Inata Y. Should we treat sepsis-induced DIC with anticoagulants? J Intensive Care. 2020;8:18. doi:10.1186/s40560-020-0435-832082582
   PubMed Web of Science ®Google Scholar